Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200213511> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4200213511 endingPage "S651" @default.
- W4200213511 startingPage "S651" @default.
- W4200213511 abstract "Abstract Background Pharmacokinetic/pharmacodynamic (PK/PD) targets and attainment are well described for beta-lactams; however, are rarely considered for beta-lactamase inhibitors. Recent evidence suggests that tazobactam (TAZ) target exposures to restore piperacillin bacteriostatic and 1 log 10 bactericidal activity against Enterobacterales are fT> the piperacillin/tazobactam (TZP) MIC of 64% and 77%, respectively. The aim of this study was to evaluate TAZ probability of target attainment (PTA) of a 500 mg every 6-hour dose of tazobactam using population PK data in both healthy volunteers and hospitalized patients. Methods PK exposures in 1,000 patients with varying degrees of renal function were simulated using a previously described TAZ PK model developed with data from critically ill infected patients. An identical one-compartment structural model describing TAZ PK using mean population parameters observed in phase 1 PK studies was also used to simulate exposures in healthy volunteers. All simulated patients received 500 mg of TAZ as an intravenous infusion over 30 minutes or as a 3-hour extended-infusion. Results The table displays PTA results for patients with an estimated creatinine clearance of 60 mL/min. Based on healthy volunteer data, the highest TZP MIC where ~90% PTA was achieved for bacteriostasis was 1 mg/L and was 0.25 mg/L for bactericidal activity. These were only achieved with extended infusion administration of TAZ. In the cohort of hospitalized patients, >90% PTA of TAZ exposures associated with both bacteriostasis and 1 log kill were achieved up to a MIC of 2 for intermittent infusion and up to 4 mg/L for extended infusion, due to decreased TAZ clearance in hospitalized patients. These values are significantly lower than the CLSI TZP susceptibility breakpoint of 16 mg/L, and PTA rates were lower at increased creatinine clearances. Conclusion fT>TZP MIC target attainment is poor with maximal package insert tazobactam doses given with piperacillin, even when administered as an extended infusion. These findings have serious implications for the role of TZP in beta-lactamase producing Enterobacterales, including ESBLs, and suggest the current susceptibility breakpoints are 4-32 fold higher than those supported by PK/PD data. Disclosures Jason M Pogue, PharmD, BCPS, BCIDP, Merck (Consultant)QPex (Consultant)Shionogi (Consultant)Utility Therapeutics (Consultant)VenatoRX (Consultant) Emily Heil, PharmD, MS, BCIDP, Nothing to disclose" @default.
- W4200213511 created "2021-12-31" @default.
- W4200213511 creator A5036700991 @default.
- W4200213511 creator A5077074926 @default.
- W4200213511 creator A5081370891 @default.
- W4200213511 date "2021-11-01" @default.
- W4200213511 modified "2023-10-17" @default.
- W4200213511 title "1117. Tazobactam Pharmacokinetic/Pharmacodynamic Target Attainment in Healthy Volunteers and Critically-Ill Hospitalized Patients" @default.
- W4200213511 doi "https://doi.org/10.1093/ofid/ofab466.1310" @default.
- W4200213511 hasPublicationYear "2021" @default.
- W4200213511 type Work @default.
- W4200213511 citedByCount "0" @default.
- W4200213511 crossrefType "journal-article" @default.
- W4200213511 hasAuthorship W4200213511A5036700991 @default.
- W4200213511 hasAuthorship W4200213511A5077074926 @default.
- W4200213511 hasAuthorship W4200213511A5081370891 @default.
- W4200213511 hasBestOaLocation W42002135111 @default.
- W4200213511 hasConcept C111113717 @default.
- W4200213511 hasConcept C112705442 @default.
- W4200213511 hasConcept C126322002 @default.
- W4200213511 hasConcept C159641895 @default.
- W4200213511 hasConcept C2777637488 @default.
- W4200213511 hasConcept C2777858937 @default.
- W4200213511 hasConcept C2778193466 @default.
- W4200213511 hasConcept C2778266534 @default.
- W4200213511 hasConcept C2780306776 @default.
- W4200213511 hasConcept C2908647359 @default.
- W4200213511 hasConcept C2991859549 @default.
- W4200213511 hasConcept C35294091 @default.
- W4200213511 hasConcept C523546767 @default.
- W4200213511 hasConcept C54355233 @default.
- W4200213511 hasConcept C71924100 @default.
- W4200213511 hasConcept C86803240 @default.
- W4200213511 hasConcept C98274493 @default.
- W4200213511 hasConcept C99454951 @default.
- W4200213511 hasConceptScore W4200213511C111113717 @default.
- W4200213511 hasConceptScore W4200213511C112705442 @default.
- W4200213511 hasConceptScore W4200213511C126322002 @default.
- W4200213511 hasConceptScore W4200213511C159641895 @default.
- W4200213511 hasConceptScore W4200213511C2777637488 @default.
- W4200213511 hasConceptScore W4200213511C2777858937 @default.
- W4200213511 hasConceptScore W4200213511C2778193466 @default.
- W4200213511 hasConceptScore W4200213511C2778266534 @default.
- W4200213511 hasConceptScore W4200213511C2780306776 @default.
- W4200213511 hasConceptScore W4200213511C2908647359 @default.
- W4200213511 hasConceptScore W4200213511C2991859549 @default.
- W4200213511 hasConceptScore W4200213511C35294091 @default.
- W4200213511 hasConceptScore W4200213511C523546767 @default.
- W4200213511 hasConceptScore W4200213511C54355233 @default.
- W4200213511 hasConceptScore W4200213511C71924100 @default.
- W4200213511 hasConceptScore W4200213511C86803240 @default.
- W4200213511 hasConceptScore W4200213511C98274493 @default.
- W4200213511 hasConceptScore W4200213511C99454951 @default.
- W4200213511 hasIssue "Supplement_1" @default.
- W4200213511 hasLocation W42002135111 @default.
- W4200213511 hasLocation W42002135112 @default.
- W4200213511 hasOpenAccess W4200213511 @default.
- W4200213511 hasPrimaryLocation W42002135111 @default.
- W4200213511 hasRelatedWork W1967652788 @default.
- W4200213511 hasRelatedWork W1980704560 @default.
- W4200213511 hasRelatedWork W1987255433 @default.
- W4200213511 hasRelatedWork W2165488979 @default.
- W4200213511 hasRelatedWork W2784001237 @default.
- W4200213511 hasRelatedWork W2978355865 @default.
- W4200213511 hasRelatedWork W3032314190 @default.
- W4200213511 hasRelatedWork W3103165157 @default.
- W4200213511 hasRelatedWork W3135923252 @default.
- W4200213511 hasRelatedWork W4200213511 @default.
- W4200213511 hasVolume "8" @default.
- W4200213511 isParatext "false" @default.
- W4200213511 isRetracted "false" @default.
- W4200213511 workType "article" @default.